Consistently delivered good results. Least PE among Healthcare stocks. PEG < 1 Good ICR , Low debt ROE, ROCE better than industry compatriots Excellent Sales and profit growth
Expecting breakout if good to great results
Nota
Excellent Results Mar 2024 NSE:NH QOQ 👉Revenue rose 6.23% to 1279cr 👉Profit rose 1.60% to 191cr 👉EPS rose 1.41% to 9.33 👉EBITDA rose 5.73% to 295 👉EBITDA Margin drops 0.00% BPS to 23% YOY 👉Revenue rose 4.66% from 1222cr 👉Profit rose 10.40% from 173cr 👉EPS rose 10.15% from 8.47 👉EBITDA rose 6.88% from 276 👉EBITDA Margin drops 0.00% BPS from 23% Fundamentals 👉Stock Price is 1296.3( as of 3/31/2024) 👉Stock PE is 33.57 👉Stock EPS is 38.62 👉Dividend Announced of Rs.4 Growth 👉2 Year Revenue CAGR is 16.48% 👉2 Year Profit CAGR is 51.98% 👉2 Year EPS CAGR is 51.94% 👉2 Year Price CAGR is 31.46%"""
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.